PUBLIC LAW 99-158—NOV. 20, 1985
99 STAT. 883
(b) COMPOSITION.—The Committee shall be composed of such representatives as the Director may designate, but shall include representatives from the National Institute of Neurological and Communicative Disorders and Stroke, the National Institute of Child Health and Human Development, the National Institute of Allergy and Infectious Diseases, the National Eye Institute, the National Institute of Environmental Health Sciences, the Division of Research Resources of the National Institutes of Health, the Food and Drug Administration, the National Institute of Mental Health, and the Department of Education. (c) REPORT.—Not later than 18 months after the date of enactment of this Act, the Committee shall report to the Congress on its activities under subsection (a) and shall include in the report— (1) the number of persons affected by learning disabilities and the demographic data which describes such persons; (2) a description of the current research findings on the cause, diagnosis, treatment, and prevention of learning disabilities; and (3) recommendations for legislation and administrative actions— (A) to increase the effectiveness of research on learning disabilities and to improve the dissemination of the findings of such research; and (B) respecting specific priorities for research in the cause, diagnosis, treatment, and prevention of learning disabilities. (d) TERMINATION.—The Committee shall terminate 90 days after the date of the submission of the report under subsection (c). SEC. 10. REVIEW OF DISEASE RESEARCH PROGRAMS OF THE NATION42 USC 285c AL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY ^°^^DISEASES.
The Secretary of Health and Human Services shall conduct an administrative review of the disease research programs of the National Institute of Diabetes and Digestive and Kidney Diseeises to determine if any of such programs could be more effectively and efficiently managed by other national research institutes. The Secretary shall complete such review within the one-year period beginning on the date of enactment of this Act. SEC. 11. BIOMEDICAL ETHICS.
Title III (as amended by section 3) is amended by adding at the end the following: "PART I—BIOMEDICAL ETHICS
"SEC. 381. (a) There is established in the legislative branch of the Government the Biomedical Ethics Board (hereinafter referred to as the 'Board'). "(b)(1) The Board shall consist of twelve members as follows: "(A) Six Members of the Senate appointed as follows: Three members appointed by the Majority Leader of the Senate from the majority party and three members appointed by the Minority Leader from the minority party. "(B) Six Members of the House of Representatives appointed by the Speaker of the House of Representatives, three from the majority party and three from the minority party.
42 USC 275.
�
